These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8408980)

  • 41. Monoamine oxidase inhibitors revisited: what you should know.
    Goldberg JF; Thase ME
    J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
    [No Abstract]   [Full Text] [Related]  

  • 42. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
    Feinberg SS
    J Clin Psychiatry; 2004 Nov; 65(11):1520-4. PubMed ID: 15554766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversible monoamine oxidase-A inhibitors in panic disorder.
    Bakish D; Saxena BM; Bowen R; D'Souza J
    Clin Neuropharmacol; 1993; 16 Suppl 2():S77-82. PubMed ID: 8313401
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of imipramine-resistant recurrent depression, III: Efficacy of monoamine oxidase inhibitors.
    Thase ME; Frank E; Mallinger AG; Hamer T; Kupfer DJ
    J Clin Psychiatry; 1992 Jan; 53(1):5-11. PubMed ID: 1737741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL; Sunderland T; Cohen RM
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine.
    Kennedy SH; Goldbloom DS; Ralevski E; Davis C; D'Souza JD; Lofchy J
    J Clin Psychopharmacol; 1993 Dec; 13(6):415-22. PubMed ID: 8120155
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid antidepressant effect of addition of lithium to tranylcypromine.
    Tariot PN; Murphy DL; Sunderland T; Mueller EA; Cohen RM
    J Clin Psychopharmacol; 1986 Jun; 6(3):165-7. PubMed ID: 3711366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
    Volz HP; Gleiter CH; Möller HJ
    Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of melancholia with tranylcypromine.
    McGrath PJ; Quitkin FM; Harrison W; Stewart JW
    Am J Psychiatry; 1984 Feb; 141(2):288-9. PubMed ID: 6691499
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K; Grohmann R; Hippius H; Rüther E
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of neurogenic orthostatic hypotension with a monoamine oxidase inhibitor and tyramine.
    Nanda RN; Johnson RH; Keogh HJ
    Acta Neurol Belg; 1976; 76(5-6):295-300. PubMed ID: 1007896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bupropion-tranylcypromine combination for treatment-refractory depression.
    Pierre JM; Gitlin MJ
    J Clin Psychiatry; 2000 Jun; 61(6):450-1. PubMed ID: 10901349
    [No Abstract]   [Full Text] [Related]  

  • 55. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder.
    Baker DG; Diamond BI; Gillette G; Hamner M; Katzelnick D; Keller T; Mellman TA; Pontius E; Rosenthal M; Tucker P
    Psychopharmacology (Berl); 1995 Dec; 122(4):386-9. PubMed ID: 8657838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MAO inhibition as antidepressive mechanism reevaluated. A controlled study with tranylcypromine isomers.
    Beckmann H; Moises HW
    Mod Probl Pharmacopsychiatry; 1983; 19():211-4. PubMed ID: 6865965
    [No Abstract]   [Full Text] [Related]  

  • 58. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
    Lotufo-Neto F; Trivedi M; Thase ME
    Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.
    Goff DC
    Am J Psychiatry; 1985 Dec; 142(12):1487-8. PubMed ID: 4073318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.